Post-thrombotic syndrome, recurrence, and death 10 years after the first episode of venous thromboembolism treated with warfarin for 6 weeks or 6 months-Reference-Cited by-同舟云学术

Post-thrombotic syndrome, recurrence, and death 10 years after the first episode of venous thromboembolism treated with warfarin for 6 weeks or 6 months

Published:2006-04 Issue:4 Volume:4 Page:734-742
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:J Thromb Haemost

Author:

SCHULMAN S.,LINDMARKER P.,HOLMSTROM M.,LARFARS G.,CARLSSON A.,NICOL P.,SVENSSON E.,LJUNGBERG B.,VIERING S.,NORDLANDER S.,LEIJD B.,JAHED K.,HJORTH M.,LINDER O.,BECKMAN M.

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1538-7836.2006.01795.x/fullpdf

Reference29 articles.

1. The Long-Term Clinical Course of Acute Deep Venous Thrombosis

2. Randomised trial of effect of compression stockings in patients with symptomatic proximal-vein thrombosis

3. The Venous Stasis Syndrome After Deep Venous Thrombosis or Pulmonary Embolism: A Population-Based Study

4. Post-thrombotic Syndrome After Primary Event of Deep Venous Thrombosis 10 to 20 Years Ago

Cited by 408 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Venous valve hypoxia as a possible mechanism of deep vein thrombosis: a scoping review;International Angiology;2024-08

2. Very long–term risk of moderate-to-severe postthrombotic syndrome after deep vein thrombosis;Journal of Thrombosis and Haemostasis;2024-08

3. High microRNA-145 plasma levels are associated with decreased risk of future incident venous thromboembolism: the HUNT study;Blood;2024-04-25

4. RNA methylation patterns, immune characteristics, and autophagy-related mechanisms mediated by N6-methyladenosine (m6A) regulatory factors in venous thromboembolism;BMC Genomics;2024-04-24

5. Genetic correlations, shared risk genes and immunity landscapes between COVID-19 and venous thromboembolism: evidence from GWAS and bulk transcriptome data;Inflammation Research;2024-03-03